ERJ Open Research

Article	Citations
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI)versusintercalated TKI with chemotherapy forEGFR-mutated nonsmall cell lung cancer	142
ERS International Congress 2021: highlights from the Epidemiology and Environment Assembly	102
An observational study ofPseudomonas aeruginosain adult long-term ventilation	80
Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosis	75
Exertional inspiratory capacity and operating lung volumes in health: a population-based study	55
Pseudomonas aeruginosainfection is linked to increases in cardiovascular events post exacerbation in bronchiectasis	54
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry	50
Coughing during spirometry is not uncommon in healthy middle-aged and elderly subjects	46
Increased loop gain and upper airway collapsibility among smoking patients with obstructive sleep apnoea	45
Uncontrolled asthma from childhood to young adulthood associates with airflow obstruction	44
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care	44
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients	39
Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis	38
Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)	38
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience	37
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough	37
Pulmonary rehabilitation in long COVID: more than just natural recovery!?	36
Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study	36
Influence of sex, season and environmental air quality on experimental human pneumococcal carriage acquisition: a retrospective cohort analysis	35
Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma	35
Pulmonary disease as a risk factor for transfusion-related acute lung injury	34
Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset	32
“Lung diffusing capacity for nitric oxide measured by two commercial devices: a randomised crossover comparison in healthy adults”. Thomas Radtke, Quintin de Groot, Sarah R. Haile, Marion Maggi, Conni	31
Defining end-systolic pressure for single-beat estimation of right ventricle–pulmonary artery coupling: simple… but not really	31
Predictors of outcome of chest tube drainage of nonpurulent exudative pleural effusions	30

Aerosol particle concentrations with different oxygen devices and interfaces for spontaneous breathing patients with tracheostomy: a randomised crossover trial	29
Blood eosinophils as a predictor of treatment response in adults with difficult-to-treat chronic cough	29
Individual trajectory-based care for COPD: getting closer, but not there yet	28
Granulomatous–lymphocytic interstitial lung disease: an international research prioritisation	26
Imprinting of bronchial epithelial cells uponin vivorhinovirus infection in people with asthma	26
Observational study of inhaled corticosteroid treatment for improved expiratory variability index in steroid-naïve asthmatic children	25
The landscape of transcriptomic and proteomic studies in sarcoidosis	25
ERS International Congress 2021: highlights from the Respiratory Infections Assembly	24
The association of lung cancer with pulmonary fibrosis	24
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab	24
Dysglycaemia among tuberculosis patients without known diabetes in a low-endemic setting	24
Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease	23
Physical activity end-points in trials of chronic respiratory diseases: summary of evidence	23
High-flow nasal cannula and noninvasive ventilation: effects on alveolar recruitment and overdistension	23
Inhaled anti-asthma therapies following hormone therapy in women: a nationwide cohort study	22
Is sleep disordered breathing a risk factor for COVID-19 orvice versa?	22
Reliability of translaryngeal airway resistance measurements during maximal exercise	22
Quality assessment pathway for respiratory oscillometry	22
The effect of oxygen and carbon dioxide cross-sensitivity sensor error in the Eco Medics Exhalyzer D device on measures of conductive and acinar airway function	21
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis	21
Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer	21
Plethysmography-derived gas trapping lacks utility in predicting response to bronchial thermoplasty	21
Lung ultrasound assessment for pneumothorax following transbronchial lung cryobiopsy	21
Relationship between biomarkers and findings on low-dose computed tomography in hospitalised patients with acute exacerbation of COPD	21
Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001–2017	21
Access, access, access: the Three A's of pulmonary rehabilitation – perspectives of patients, loved ones and healthcare professionals	21
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis	20
Transition of patients with interstitial lung disease from paediatric to adult care	20
Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease	20
Bronchial thermoplasty guided by hyperpolarised gas magnetic resonance imaging in adults with severe asthma: a 1-year pilot randomised trial	20
Sex-specific longitudinal association of DNA methylation with lung function	20
Pattern of cancer patient referral and organisational model of an interventional pulmonology programme during the COVID-19 pandemic	20
Early risk prediction in idiopathicversusconnective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment	19
Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis	19
Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids	19
“Expression of endocannabinoid system components in human airway epithelial cells: impact of sex and chronic respiratory disease status”. Matthew F. Fantauzzi, Jennifer A. Aguiar, Benjamin J-M. Trembl	19
Conservative management of COVID-19 associated hypoxaemia	19
Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era	19
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design	18
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe	18
Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes	18
Spirometry at different Latin-American altitudes: A Global Lung Function Initiative project	18
Quantification of aerosol dispersal from suspected aerosol-generating procedures	18
Dual CFTR modulator therapy efficacy in the real world: lessons for the future	18
Oropharyngeal enlargement in obstructive lung disease: quantification and machine learning	18
Assessing usability of QIAreach QuantiFERON-TB platform in a high tuberculosis prevalence, low-resource setting	18
Artificial intelligence based software facilitates spirometry quality control in asthma and COPD clinical trials	17
Cardiovascular disease-linked plasma proteins are mainly associated with lung volume	17
Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension	17
Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort	17

Clinical impact of routine sleep assessment by peripheral arterial tonometry in patients with COPD	17
Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality	17
Real-world diffusing capacity simulation data: how well do they fit current European Respiratory Society/American Thoracic Society acceptability criteria?	17
Sonographic follow-up of diaphragm function in COVID-19: an exploratory study	16
ERS International Congress 2022: highlights from the Basic and Translational Science Assembly	16
A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19	16
Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis	16
ERS International Congress 2022: highlights from the Sleep Disordered Breathing Assembly	16
Interleukin-11 disrupts alveolar epithelial progenitor function	16
Efficacy and tolerability of zinc acetate for treatment of chronic refractory cough: pilot randomised futility trial	16
Eradication ofBurkholderia cepaciacomplex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole	16
Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients	16
Broadening the scope for three-dimensional printed airway stents	16
Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis	16
NICE asthma guidelines: time to re-evaluate the diagnostic value of exercise challenge testing?	16
Effects of pH alteration on respiratory syncytial virus in human airway epithelial cells	16
An analysis of sex differences in pulmonary arteriovenous malformation presentation, complications and management in a large, multinational registry of patients with hereditary haemorrhagic telangiect	15
Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis	15
External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis	15
Additive value of lung ultrasound to clinical parameters for prognosticating COVID-19	15
Diagnostic options for pulmonary fungal diseases in Africa	15
High use of short-acting β2-agonists in COPD is associated with an increased risk of exacerbations and mortality	15
A typology of healthcare pathways after hospital discharge for adults with COVID-19: the evolution of UK services during pandemic conditions	14
The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis	14
Assessing post-COVID-19 respiratory dynamics: a comprehensive analysis of pulmonary function, bronchial hyperresponsiveness and bronchodilator response	14
Williams–Campbell syndrome case series and discordant twins	14
Previous tuberculosis infection associated with increased frequency of asthma and respiratory symptoms in a Nordic–Baltic multicentre population study	14
Lung function improvement on triple modulators: high-resolution, nationwide data from the Danish Cystic Fibrosis Cohort	14
Achieving adherence to positive airway pressure in commercial drivers using an employer-mandated remote management programme	14
Matrix metalloprotease-7 is associated with post-COVID-19 persistent lung abnormalities	14
Lipomatous hypertrophy of the interatrial septum: a distinct adipose tissue type in COPD?	14
Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey	14
Lack of efficacy of tocilizumab in acute exacerbation of pulmonary fibrosis	14
Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial	14
International consensus statement on routine blood testing in primary ciliary dyskinesia	13
Time interval for QuantiFERON-TB Gold Plus conversion after last exposure with tuberculosis	13
Biomarkers troponin and procalcitonin in addition to CRB-65 enhance risk stratification in patients with community-acquired pneumonia	13
Altered ventricular repolarisation dynamic: the missing link between obstructive sleep apnoea and sudden death?	13
Characterizing dysfunctional breathing seen in post-acute sequelae of Sars-Cov-2 using approximate entropy	13
Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturation	13
Myostatin and smad2/smad3 pathway define a differential clinical phenotype in Copd-associated Sarcopenia	13
Supporting clinical trial recruitment in COPD by leveraging lung cancer screening: an observational study	13
PROTEA study: a protocol for a randomised controlled trial evaluating the efficacy, immune effects and cost-effectiveness of oral bacterial lysate (OM-85) therapy to protect moderate-late preterm infa	13
Interleukin 33: a suitable target for biological therapies of COPD?	13
Endobronchial valve treatment improves diaphragm function in severe emphysema patients	13
Penetrance of interstitial lung disease and lung cancer in carriers ofSFTPA1orSFTPA2pathogenic variants	12
Exploring the roles of airway dipeptidyl peptidase 1 in obstructive airway disease	12
COVID-19-related organising pneumonia in patients with secondary antibody deficiency responds to immune globulin	12
Proteins associated with preserved ratio impaired spirometry (PRISm)	12
Artificial neural network risk prediction of chronic obstructive pulmonary disease (COPD) exacerbations using urine biomarkers	12
Resistive breathing aggravates cigarette smoke-induced pulmonary inflammation	12
Association of MYH10 with clinical variables in obstructive lung diseases	12
Wasted ventilation in mild COPD: protocol for a clinical physiology and functional imaging study	12
Artificial intelligence-based echocardiography assessment to detect pulmonary hypertension	12
Development and external validation of a model for lung transplantation-free survival prediction of primary Sjögren's syndrome-associated interstitial lung disease: a prospective cohort study	12
The electronic nose in lung cancer diagnostics: A systematic review and meta-analysis	12
ERS Congress 2024: Highlights from the respiratory infections assembly	12
Short term effects of e-cigarettes smoking on cardio-respiratory parameters, volatile organic compounds and inflammatory markers	12
Lung parenchymal and cardiac appearances on CTPA impact survival in chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry	12
Sleep disordered breathing in children with primary ciliary dyskinesia	12
Social support and recovery in ARDS survivors: a prospective cohort study	12
Mechanically assisted cough strategies: user perspectives and cough flows in children with neurodisability	12
Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19	11
Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance	11
Pulmonary radioaerosol mucociliary clearance assessment: searching for genotype-specific differences and potential as an outcome measure in primary ciliary dyskinesia	11
Sarcoidosis lung transplantation waitlist mortality, a national registry database study	11
Transition to endemic: 2-year SARS-CoV-2 surveillance follow-up of the ELISA cohort	11
Differential expression of mast cells in the small airways and alveolar septa of current smokers and patients with small airway disease and COPD	11
Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis	11
Association of patient-reported outcome measures with lung function and mortality in fibrotic interstitial lung disease: a prospective cohort study	11
Anodal transcranial direct current stimulation over the right primary somatosensory cortex increases cough reflex sensitivity: a pilot randomised controlled crossover trial	11
Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan	11
Chronic cough associated with COPD exacerbation, pneumonia and death in the general population	11
Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on	11
Update on metabolomic findings in COPD patients	11
Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial	11
Influence of ethnicity on adherence to nonsurgical interventions for COPD: a scoping review	11
Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study	11
Cardiopulmonary exercise testing and body composition	11
Feasibility and value of a domiciliary spirometry programme in the assessment of severe asthma: a real-world evaluation	11

ERS International Congress 2023: highlights from the Interstitial Lung Diseases Assembly	11
Cardiomyopathy as cause of death in Duchenne muscular dystrophy: a longitudinal observational study	11
Idiopathic interstitial pneumonia in a patient with von Hippel–Lindau syndrome: a first case	11
Prednisolone for COPD exacerbations: time for a rethink	11
An adaptation strategy to urban heat: hospital rooms with radiant cooling accelerate patient recovery	10
Immunophenotypes of anti-SARS-CoV-2 responses associated with fatal COVID-19	10
Period and cohort effects: consequences on spirometric lung function in Norway during the 20th century	10
Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score	10
Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort	10
Improving the wellbeing of caregivers of patients with COPD using a home-based pulmonary rehabilitation programme	10
Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis	10
Defining the normal range of fractional exhaled nitric oxide in children: one size does not fit all	10
Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma	10
Multidisciplinary care in chronic airway diseases: the Newcastle model	10
Outcome prediction model and prognostic biomarkers for COVID-19 patients in Vietnam	10
Feasibility of transbronchial lung cryobiopsy in patients with veno-venous extracorporeal membrane oxygenation support	10
Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension	10
Functional clinical impairments and frailty in interstitial lung disease patients	10
When more is more: the role of additional upfront therapy in pulmonary arterial hypertension	10
Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study	10
Computed tomography on lung cancer screening is useful for adjuvant comorbidity diagnosis in developing countries	10
ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly	10
Heated tobacco product IQOS induces unique metabolic signatures in human bronchial epithelial cells	10
Family case studies: absence ofPseudomonas aeruginosatransmission in bronchiectasis	10
Triple therapy in COPD: understanding the data	10
Lung microhaemorrhage drives oxidative/inflammatory damage in α1-antitrypsin deficiency	10
Functional imaging in asthma and COPD: design of the NOVELTY ADPro substudy	10
An exploratory study evaluating the use of coping strategies while driving in obstructive sleep apnoea syndrome patients and controls	9
Real-world usage and response to gefapixant in refractory chronic cough	9
1H-NMR urine metabolomic fingerprint for severity discrimination in pulmonary sarcoidosis	9
Decoding the impact of the placebo response in clinical trials for chronic cough	9
Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study	9
Lung cancer among outpatients with COPD: a 7-year cohort study	9
Effectiveness of a long-term acupuncture treatment in patients with chronic obstructive pulmonary disease: a randomised controlled trial	9
Development and initial validation of a disease-specific instrument to measure health-related quality of life in hypersensitivity pneumonitis	9
Prevalence, time trends and treatment practices of asthma in India: the Global Asthma Network study	9
Antitrypsin deficiency: still more to learn about the lung after 60 years	9
INTREPID: single-versusmultiple-inhaler triple therapy for COPD in usual clinical practice	9
A survey of UK respiratory specialists’ opinion on the management of chronic cough	9
The effect of moderate to late preterm birth on lung function over the first 5 years of life in a South African birth cohort	9
High-frequency percussive ventilation in acute respiratory failure	9
ERJ Open Research2024: achievements, vision and gratitude	9
Role of pulmonary rehabilitation in extracellular matrix protein expression in vastus lateralis muscle in atrophic and nonatrophic patients with COPD	9
Postural balance in COPD with obstructive sleep apnoea: a cross-sectional study	9
Low-grade systemic inflammation and peripheral airway function	9
COPD Assessment Test and risk of readmission in patients with bronchiectasis: a prospective cohort study	9
A new approach to computed tomography measurement of airway remodelling in paediatric asthma	9
The noninvasive ventilation outcomes score in patients requiring NIV for COPD exacerbation without prior evidence of airflow obstruction	9
Validation of the modified BODE index using the activity domain of St. George's Respiratory Questionnaire	9
Reductions in hospitalisations and emergency department visits with early antibiotic initiation in nontuberculous mycobacterial lung disease	9
Differential Platelet Protein Release Profiles in Community-Acquired Pneumonia and COVID-19	9
“Does COVID-19 vaccination increase the risk of interstitial lung disease at a population level?” Taehee Kim, Hyun Lee, Cho Yun Jeong, Sang Woo Yeom, Bo-Guen Kim, Tai Sun Park, Dong Won Park, Ji-Yong	9
High prevalence of interstitial lung abnormalities in middle-aged never-smokers	9
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo	9
A comprehensive evaluation of murine and humanex vivocultured alveolar macrophages	9
Long-term incident severe outcomes in a prospective cohort of non-obese obstructive sleep apnoea patients free of comorbidities at inclusion	9
The carbon footprint of diagnostic delays in asthma	9
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome: a neurogenic cough prototype	9
DElaying disease Progression In COPD with early escalation to Triple therapy – A Modelling Study (DEPICT-2)	9
Amyloid-β and caspase-1 are indicators of sepsis and organ injury	9
Upfront triple therapy with parenteral prostanoid as a bridge to balloon pulmonary angioplasty in severe chronic thromboembolic pulmonary hypertension	9
Falling through the cracks: what happens to survivors of preterm birth?	9
COPD: systemic proteomic profiles in frequent and infrequent exacerbators	9
Diagnostic delay in bronchiectasis: an Italian perspective	9
Comprehensive geriatric assessment for people with both COPD and frailty starting pulmonary rehabilitation: a mixed-methods feasibility trial	9
Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant trajectory	9
Breathversussaliva for lung cancer detection with dogs	9
Diagnosis of pulmonary embolism in patients with haemoptysis: the POPEIHE study	9
Comparison of the effects of electronic cigarette vapours and tobacco smoke extracts on human neutrophilsin vitro	9
“Age-related changes in the neural gating of respiratory sensations in humans”. Wen-Pin Chang, Kai-Jie Liang, Chia-Hsiung Cheng, Chia-Yih Liu, Andreas von Leupoldt and Pei-Ying S. Chan.ERJ Open Res	9
Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung disease	9
Utility of microRNA analysis in exhaled breath condensate of sarcoidosis and mediastinal tuberculosis patients: a pilot study	9
Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis	9
Long-term associations of PM1versusPM2.5and PM10with asthma and asthma-related respiratory symptoms in the middle-aged and elderly population	9
Targeted DNase treatment of obstructive lung disease: a pilot randomised controlled trial	9
Association of blood inflammatory phenotypes and asthma burden in children with moderate-to-severe asthma	9
As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort	9
Artificial intelligence augmentation raises questions about the future of bronchoscopy	9
Unmet need in pulmonary hypertension-associated interstitial lung disease (PH-ILD): a clinician survey of real-world management of PH-ILD in Europe	9
“Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.” Michael R. Loebinger, Stefano Aliberti, Charles Haw	9
“Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI)versusintercalated TKI with chemotherapy forEGFR-mutated nonsmall cell lung cancer”. Rolof G.P. Gijtenbeek, Vinc	9
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma	8
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis	8
Progression of Interstitial Lung Disease After the Envisia Genomic Classifier	8
Respiratory syncytial virus-associated hospitalisation in children aged ≤5 years: a scoping review of literature from 2009 to 2021	8
Short-acting β2-agonists and exacerbations in children with asthma in England: SABINA Junior	8
Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension	8
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions	8
Definitions of non-response and response to biological therapy for severe asthma: a systematic review	8
Global survey of physician testing practices for nontuberculous mycobacteria	8
Acute and durable effect of inhaled hypertonic saline on mucociliary clearance in adult asthma	8
Asthma exacerbations and eosinophilia in the UK Biobank: a genome-wide association study	8
Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition	8
Clinical characteristics of chylothorax: results from the International Collaborative Effusion database	8
Clinical and research priorities for children and young people with bronchiectasis: an international roadmap	8